X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Abbott India with Elder Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ABBOTT INDIA vs ELDER PHARMA - Comparison Results

ABBOTT INDIA    Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ABBOTT INDIA ELDER PHARMA ABBOTT INDIA/
ELDER PHARMA
 
P/E (TTM) x 40.6 -0.2 - View Chart
P/BV x 11.7 0.1 11,637.0% View Chart
Dividend Yield % 0.5 0.0 -  

Financials

 ABBOTT INDIA   ELDER PHARMA
EQUITY SHARE DATA
    ABBOTT INDIA
Mar-17
ELDER PHARMA
Jun-14
ABBOTT INDIA/
ELDER PHARMA
5-Yr Chart
Click to enlarge
High Rs5,190380 1,365.8%   
Low Rs4,351188 2,314.4%   
Sales per share (Unadj.) Rs1,382.9491.2 281.5%  
Earnings per share (Unadj.) Rs130.2-3.2 -4,091.9%  
Cash flow per share (Unadj.) Rs137.914.4 957.2%  
Dividends per share (Unadj.) Rs40.000-  
Dividend yield (eoy) %0.80-  
Book value per share (Unadj.) Rs652.7376.5 173.3%  
Shares outstanding (eoy) m21.2520.54 103.5%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.40.6 596.6%   
Avg P/E ratio x36.6-89.3 -41.1%  
P/CF ratio (eoy) x34.619.7 175.5%  
Price / Book Value ratio x7.30.8 969.0%  
Dividend payout %30.70-   
Avg Mkt Cap Rs m101,3735,833 1,737.8%   
No. of employees `0003.1NA-   
Total wages/salary Rs m3,4532,179 158.5%   
Avg. sales/employee Rs Th9,531.9NM-  
Avg. wages/employee Rs Th1,119.9NM-  
Avg. net profit/employee Rs Th897.3NM-  
INCOME DATA
Net Sales Rs m29,38710,089 291.3%  
Other income Rs m576257 224.6%   
Total revenues Rs m29,96310,346 289.6%   
Gross profit Rs m3,973-792 -501.7%  
Depreciation Rs m164361 45.5%   
Interest Rs m202,756 0.7%   
Profit before tax Rs m4,365-3,653 -119.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m03,713 0.0%   
Tax Rs m1,598125 1,277.2%   
Profit after tax Rs m2,767-65 -4,233.4%  
Gross profit margin %13.5-7.8 -172.3%  
Effective tax rate %36.6-3.4 -1,068.9%   
Net profit margin %9.4-0.6 -1,453.4%  
BALANCE SHEET DATA
Current assets Rs m18,9069,240 204.6%   
Current liabilities Rs m6,2979,998 63.0%   
Net working cap to sales %42.9-7.5 -571.3%  
Current ratio x3.00.9 324.9%  
Inventory Days Days6246 134.3%  
Debtors Days Days2260 36.1%  
Net fixed assets Rs m1,15910,124 11.4%   
Share capital Rs m213206 103.3%   
"Free" reserves Rs m13,6575,582 244.6%   
Net worth Rs m13,8697,734 179.3%   
Long term debt Rs m04,889 0.0%   
Total assets Rs m20,63822,882 90.2%  
Interest coverage x215.0-0.3 -66,084.1%   
Debt to equity ratio x00.6 0.0%  
Sales to assets ratio x1.40.4 322.9%   
Return on assets %13.511.8 114.8%  
Return on equity %19.9-0.8 -2,360.5%  
Return on capital %31.622.3 141.7%  
Exports to sales %03.0 0.0%   
Imports to sales %00.4 0.0%   
Exports (fob) Rs mNA307 0.0%   
Imports (cif) Rs mNA43 0.0%   
Fx inflow Rs m0307 0.0%   
Fx outflow Rs m0125 0.0%   
Net fx Rs m0181 0.0%   
CASH FLOW
From Operations Rs m3,07211,754 26.1%  
From Investments Rs m-1,554-561 277.3%  
From Financial Activity Rs m-898-6,762 13.3%  
Net Cashflow Rs m6214,432 14.0%  

Share Holding

Indian Promoters % 0.0 39.6 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 7.9 7.5 105.3%  
FIIs % 0.1 16.8 0.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 17.1 36.1 47.4%  
Shareholders   18,270 16,479 110.9%  
Pledged promoter(s) holding % 0.0 77.6 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ABBOTT INDIA With:   GLENMARK PHARMA  J.B.CHEMICALS  MERCK LTD  BIOCON LTD  FULFORD INDIA  

Compare ABBOTT INDIA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 219 Points Lower; Energy and Auto Stocks Witness Selling(Closing)

After witnessing volatile trades during the day, Indian share markets ended their session on a negative note. Losses were largely seen in the oil & gas sector, auto sector.

Related Views on News

ABBOTT INDIA at All Time High; BSE HEALTHCARE Index Up 0.5%

Jun 25, 2018 | Updated on Jun 25, 2018

ABBOTT INDIA share price has hit an all time high at Rs 7,550 (up 1.60%). The BSE HEALTHCARE Index is up by 0.49%. Among the top gainers in the BSE HEALTHCARE Index today are ABBOTT INDIA (up 1.60%) and SANOFI INDIA (up 0.37%). The top losers include GSK PHARMA (down 0.04%) and JUBILANT LIFE SCIENCES (down 0.13%).

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

More Views on News

Most Popular

Alert: Pharma Stocks Are About to Shoot Up - And a Superb Stock for Trading(Profit Hunter)

Jun 13, 2018

The ailing pharma stocks are bouncing back to health. Read this to find out the best way to profit from them.

Will You Dump Your Client if You're Busy? Inox Wind's Auditor Just Did...(The 5 Minute Wrapup)

Jun 14, 2018

After Inox Wind, you may see more auditors resigning And the reasons can be as funny as they can get.

GST Will Not Solve Problem of High Prices of Petrol and Diesel(Vivek Kaul's Diary)

Jun 13, 2018

Though it will bring transparency in their pricing and that in itself will be a welcome move.

Should You Invest In Mirae Asset Healthcare Fund?(Outside View)

Jun 15, 2018

Mirae Asset Mutual Fund launches NFO - Mirae Asset Helathcare Fund.

This Behaviour is Injurious to Wealth Building(Sector Info)

Jun 13, 2018

Blindly following the herd can be the biggest wealth destroyer.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ABBOTT INDIA SHARE PRICE


Jun 25, 2018 (Close)

TRACK ABBOTT INDIA

  • Track your investment in ABBOTT INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ABBOTT INDIA 8-QTR ANALYSIS

COMPARE ABBOTT INDIA WITH

MARKET STATS